|
MAGEE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.12880002304195E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.01779995332186E-09 |
| Normal-vs-Stage2 |
3.800100E-04 |
| Normal-vs-Stage3 |
5.288200E-02 |
| Normal-vs-Stage4 |
8.082300E-03 |
| Stage1-vs-Stage2 |
9.992800E-01 |
| Stage1-vs-Stage3 |
8.016100E-02 |
| Stage1-vs-Stage4 |
6.606400E-01 |
| Stage2-vs-Stage3 |
2.307800E-01 |
| Stage2-vs-Stage4 |
6.861800E-01 |
| Stage3-vs-Stage4 |
2.150400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73080000331893E-08 |
| Normal-vs-AfricanAmerican |
1.70667999999097E-05 |
| Normal-vs-Asian |
9.641900E-03 |
| Caucasian-vs-AfricanAmerican |
8.734200E-01 |
| Caucasian-vs-Asian |
9.979800E-01 |
| AfricanAmerican-vs-Asian |
9.547800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.09035044618622E-12 |
| Normal-vs-Female |
3.951600E-01 |
| Male-vs-Female |
2.99689999483377E-08 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.821300E-04 |
| Normal-vs-Extreme_Weight |
1.64409996727954E-09 |
| Normal-vs-Obese |
5.178100E-04 |
| Normal-vs-Extreme_Obese |
1.56707999999783E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.503760E-01 |
| Normal_Weight-vs-Obese |
7.632800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.984830E-01 |
| Extreme_Weight-vs-Obese |
5.145700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.999600E-01 |
| Obese-vs-Extreme_Obese |
9.745500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.165200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.90719999998623E-06 |
| Normal-vs-Age(61-80Yrs) |
8.40889580189241E-11 |
| Normal-vs-Age(81-100Yrs) |
2.018100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.338040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.416600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.281990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.356500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.934000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.987200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.76550029940393E-10 |
| Normal-VS-Type2 PRCC |
2.00899999969195E-08 |
| Normal-VS-KIRP CIMP |
6.755200E-01 |
| Normal-VS-Unclassified PRCC |
1.680160E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.887200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.964700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.873740E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.382040E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.911900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.278000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.19240000890409E-09 |
| Normal-vs-N1 |
2.817000E-01 |
| Normal-vs-N2 |
9.260200E-02 |
| N0-vs-N1 |
2.345900E-02 |
| N0-vs-N2 |
3.407000E-01 |
| N1-vs-N2 |
7.046200E-01 |
|
|
